NCT06364605

Brief Summary

My Space aims to identify the ontogenesis of spatial representation through cross-sectional and longitudinal studies in infants, children, and adolescents with typical and atypical development (visual impairments). The results will serve for the design and development of a novel multisensory device for sensorimotor rehabilitation in blind children from the early stages of life.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
720

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 26, 2021

Completed
2.8 years until next milestone

First Submitted

Initial submission to the registry

March 26, 2024

Completed
20 days until next milestone

First Posted

Study publicly available on registry

April 15, 2024

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 15, 2024

Status Verified

March 1, 2024

Enrollment Period

2 months

First QC Date

March 26, 2024

Last Update Submit

April 9, 2024

Conditions

Keywords

blindnessinfantsspatial representationsEEGchild developmentmedical device

Outcome Measures

Primary Outcomes (7)

  • Perceptual responses to multisensory stimuli

    Evaluation of the number of correct responses and reaction times (in seconds), to uni- and multisensory (audio-tactile) stimuli.

    Through study completion, an average of 5 years

  • Stimuli velocity perception

    Estimation of the speed of a moving stimulus (m/s)

    Through study completion, an average of 5 years

  • Distance stimuli perception

    Estimation of the the distance traveled by a moving stimulus (m), along with an estimate of the error made in identifying the endpoint of the stimulus by the participant (m).

    Through study completion, an average of 5 years

  • Eye movements

    Eye movements are evaluated in terms of fixation duration (s) and time to first fixation (TTFF) (ms).

    Years 3-5

  • Saccade Analysis

    Estimation of saccade length (pixels)

    Years 3-5

  • ERP evaluation and analysis

    Evaluation of the Event-Related-Potentials (ERPs) in terms of the number of spikes and their Amplitude (μV);

    Through study completion, an average of 5 years

  • Power of the cortical activity

    Evaluation of power expressed by the alpha band (8-12 Hz) of the EEG recorded in the occipital area (dB).

    Through study completion, an average of 5 years

Study Arms (1)

iReach Device Group

EXPERIMENTAL
Device: Rehabilitation with the iReach novel multisensory medical device

Interventions

From the results of Phases 1,2 and 3, in Phase 4 a medical device for spatial and sensorimotor rehabilitation in infants aged 3 to 36 months will be tested and developed.

iReach Device Group

Eligibility Criteria

Age3 Months+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Having provided (by the subject or the parent/guardian) consent to be contacted through one of the recruitment channels established by the Italian Institute of Technology or voluntary enrollment;
  • Signature of the informed consent (by the subject or the parent/guardian);
  • Absence of other disabilities/conditions/comorbidities that would prevent participation and/or ensure patient safety during the execution of the tests and/or guarantee the quality/reliability of the data. This point is acquired through Informed Consent, in the section expressly acknowledging the following reasons for ineligibility to participate in the study: tactile hypersensitivity (specifically assessing equipment tolerance), taking neuroactive drugs and substances and having taken them in the last six months, comorbidity with another pathology;
  • Being affected, to the best of their knowledge, by pathologies of the central nervous system, and having experienced epileptic episodes, even minor ones, and convulsive crises in general, even in childhood;
  • The participating subjects may have typical or atypical development (i.e., group with visual disability). In the case of visual impairment, the disability should be congenital (from birth) or late onset. Furthermore, the following requirements must be met: subjects with visual disabilities must be classified according to current diagnostic rules, with visual problems present from birth or occurring later, with residual vision ranging from 0.5-1.3 LogMAR in the case of low vision or lower than 1.3 LogMAR in the case of blindness;
  • Age range required for each phase and configuration: Blind adults (≥ 18 years old):
  • Phase 1; Phase 2; Phase 3; Typical adults (≥ 18 years old): Phase 1; Phase 2; Phase 3; Blind minors (3 months \< age \< 18 years old): All phases; Typical minors (3 months \< age \< 18 years old): All phases; Adequate cognitive capacity for age. In particular, recognized scales such as the WISC9 scale will be used as a reference parameter to assess cognitive capacity.

You may not qualify if:

  • Additional disabilities besides visual impairment (e.g., individuals who are both visually and hearing impaired);
  • Absence of the signature on the informed consent form or incomplete consent regarding acknowledgment of the incompatibilities for participation in the study;
  • IQ values below the threshold of normality according to one of the recognized international scales;
  • Preterm birth.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Unit For Visually Impaired People

Genova, 16152, Italy

Location

Related Publications (23)

  • Gori M. Multisensory Integration and Calibration in Children and Adults with and without Sensory and Motor Disabilities. Multisens Res. 2015;28(1-2):71-99. doi: 10.1163/22134808-00002478.

  • Gori M, Sandini G, Burr D. Development of visuo-auditory integration in space and time. Front Integr Neurosci. 2012 Sep 17;6:77. doi: 10.3389/fnint.2012.00077. eCollection 2012.

  • Gori M, Sandini G, Martinoli C, Burr DC. Impairment of auditory spatial localization in congenitally blind human subjects. Brain. 2014 Jan;137(Pt 1):288-93. doi: 10.1093/brain/awt311. Epub 2013 Nov 21.

  • Finocchietti S, Cappagli G, Gori M. Encoding audio motion: spatial impairment in early blind individuals. Front Psychol. 2015 Sep 7;6:1357. doi: 10.3389/fpsyg.2015.01357. eCollection 2015.

  • Cappagli G, Gori M. Auditory spatial localization: Developmental delay in children with visual impairments. Res Dev Disabil. 2016 Jun-Jul;53-54:391-8. doi: 10.1016/j.ridd.2016.02.019. Epub 2016 Mar 19.

  • Barutchu A, Crewther DP, Crewther SG. The race that precedes coactivation: development of multisensory facilitation in children. Dev Sci. 2009 Apr;12(3):464-73. doi: 10.1111/j.1467-7687.2008.00782.x.

  • Inuggi A, Pichiecchio A, Ciacchini B, Signorini S, Morelli F, Gori M. Multisystemic Increment of Cortical Thickness in Congenital Blind Children. Cereb Cortex Commun. 2020 Oct 9;1(1):tgaa071. doi: 10.1093/texcom/tgaa071. eCollection 2020.

  • Mongodi S, Ottonello G, Viggiano R, Borrelli P, Orcesi S, Pichiecchio A, Balottin U, Mojoli F, Iotti GA. Ten-year experience with standardized non-operating room anesthesia with Sevoflurane for MRI in children affected by neuropsychiatric disorders. BMC Anesthesiol. 2019 Dec 18;19(1):235. doi: 10.1186/s12871-019-0897-1.

  • Erden G, Yigit I, Celik C, Guzey M. The diagnostic utility of the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV) in identification of gifted children. J Gen Psychol. 2022 Jul-Sep;149(3):371-390. doi: 10.1080/00221309.2020.1862038. Epub 2020 Dec 22.

  • Lawrence A, Choe DE. Mobile Media and Young Children's Cognitive Skills: A Review. Acad Pediatr. 2021 Aug;21(6):996-1000. doi: 10.1016/j.acap.2021.01.007. Epub 2021 Jan 21.

  • Cappagli G, Cocchi E, Gori M. Auditory and proprioceptive spatial impairments in blind children and adults. Dev Sci. 2017 May;20(3). doi: 10.1111/desc.12374. Epub 2015 Nov 27.

  • Vercillo T, Burr D, Sandini G, Gori M. Children do not recalibrate motor-sensory temporal order after exposure to delayed sensory feedback. Dev Sci. 2015 Sep;18(5):703-12. doi: 10.1111/desc.12247. Epub 2014 Nov 28.

  • Tonelli A, Brayda L, Gori M. Task-dependent calibration of auditory spatial perception through environmental visual observation. Front Syst Neurosci. 2015 Jun 2;9:84. doi: 10.3389/fnsys.2015.00084. eCollection 2015.

  • Cuturi LF, Gori M. The Effect of Visual Experience on Perceived Haptic Verticality When Tilted in the Roll Plane. Front Neurosci. 2017 Dec 6;11:687. doi: 10.3389/fnins.2017.00687. eCollection 2017.

  • Aggius-Vella E, Campus C, Finocchietti S, Gori M. Audio Spatial Representation Around the Body. Front Psychol. 2017 Nov 3;8:1932. doi: 10.3389/fpsyg.2017.01932. eCollection 2017.

  • Campus C, Sandini G, Concetta Morrone M, Gori M. Spatial localization of sound elicits early responses from occipital visual cortex in humans. Sci Rep. 2017 Sep 5;7(1):10415. doi: 10.1038/s41598-017-09142-z.

  • Campus C, Brayda L, De Carli F, Chellali R, Fama F, Bruzzo C, Lucagrossi L, Rodriguez G. Tactile exploration of virtual objects for blind and sighted people: the role of beta 1 EEG band in sensory substitution and supramodal mental mapping. J Neurophysiol. 2012 May;107(10):2713-29. doi: 10.1152/jn.00624.2011. Epub 2012 Feb 15.

  • Rigato S, Begum Ali J, van Velzen J, Bremner AJ. The neural basis of somatosensory remapping develops in human infancy. Curr Biol. 2014 Jun 2;24(11):1222-6. doi: 10.1016/j.cub.2014.04.004. Epub 2014 May 22.

  • Klostermann A, Hossner EJ. The Quiet Eye and Motor Expertise: Explaining the "Efficiency Paradox". Front Psychol. 2018 Feb 8;9:104. doi: 10.3389/fpsyg.2018.00104. eCollection 2018.

  • Richmond J, Nelson CA. Relational memory during infancy: evidence from eye tracking. Dev Sci. 2009 Jul;12(4):549-56. doi: 10.1111/j.1467-7687.2009.00795.x.

  • Stoll J, Chatelle C, Carter O, Koch C, Laureys S, Einhauser W. Pupil responses allow communication in locked-in syndrome patients. Curr Biol. 2013 Aug 5;23(15):R647-8. doi: 10.1016/j.cub.2013.06.011.

  • Takacs ZK, Bus AG. Benefits of Motion in Animated Storybooks for Children's Visual Attention and Story Comprehension. An Eye-Tracking Study. Front Psychol. 2016 Oct 13;7:1591. doi: 10.3389/fpsyg.2016.01591. eCollection 2016.

  • Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004 Mar 15;134(1):9-21. doi: 10.1016/j.jneumeth.2003.10.009.

MeSH Terms

Conditions

BlindnessVision Disorders

Interventions

Rehabilitation

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsNervous System DiseasesEye DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AftercareContinuity of Patient CarePatient CareTherapeuticsHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 26, 2024

First Posted

April 15, 2024

Study Start

May 3, 2021

Primary Completion

June 26, 2021

Study Completion

December 31, 2025

Last Updated

April 15, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

Locations